CHEOY:OTCMKTS
Cochlear
44,64 USD
arrow_downward
-0,40%(-0,18) 1G
9 ott, 16:00:00 GMT-4 · USD
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per CHEOY in corso…
Apertura
44,80 USD
Massimo
44,86 USD
Minimo
44,55 USD
Cap. mercato
8,40 Mld
Vol. medio
23,98K
Volume
8,99K
Max 52 sett.
98,49 USD
Min 52 sett.
31,82 USD
Beta
0,68
Azioni in circolazione
130,80 Mln
N. di dipendenti
5K
Apertura
44,80 USD
Massimo
44,86 USD
Minimo
44,55 USD
Cap. mercato
8,40 Mld
Vol. medio
23,98K
Volume
8,99K
Max 52 sett.
98,49 USD
Min 52 sett.
31,82 USD
Beta
0,68
Azioni in circolazione
130,80 Mln
N. di dipendenti
5K
Articoli giornalistici
Da fonti web e partner giornalistici
Giocare in Borsa Online
·
1 giorno fa
Dell batte l’S&P 500: ritorno annuo al 65% in cinque anni
www.giocareinborsa.com
·
2 ore fa
Wall Street aspetta ASML e Taiwan Semi: S&P 500 vicino ai massimi
Investire.biz
·
3 ore fa
Utili S&P 500 nel terzo trimestre: FactSet stima un +30%
Profilo
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
Informazioni su Cochlear
CEODig Howitt
Dipendenti5,4K
Data di fondazione1981
SedeSydney, Nuovo Galles del Sud, Australia
Settore-
Sito webcochlear.com